Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice. (2018)

First Author: Tinklenberg JA
Attributed to:  Determining how mutations in actin lead to skeletal muscle weakness funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddx431

PubMed Identifier: 29293963

Publication URI: http://europepmc.org/abstract/MED/29293963

Type: Journal Article/Review

Volume: 27

Parent Publication: Human molecular genetics

Issue: 4

ISSN: 0964-6906